Featured Research

from universities, journals, and other organizations

New Study Calculates Millions Of Years Saved In Lives Of AIDS Patients

Date:
June 1, 2006
Source:
Infectious Diseases Society of America
Summary:
This year, the US federal government will spend $21 billion for HIV/AIDS research, treatment, prevention, and related activities. Is this enormous expenditure paying off? A study published in the July 1 issue of The Journal of Infectious Diseases, now available online, indicates that it is -- and more so than previously thought.

This year, the U.S. federal government will spend $21 billion for HIV/AIDS research, treatment, prevention, and related activities. Is this enormous expenditure paying off? A study published in the July 1 issue of The Journal of Infectious Diseases, now available online, indicates that it is--and more so than previously thought.

The study, by Rochelle P. Walensky, MD, MPH, Kenneth Freedberg , MD, MSc and colleagues at Massachusetts General Hospital and other centers appears at a time the world contemplates the 25-year anniversary of the first reported cases of AIDS and celebrates the 10-year anniversary of the use of multi-drug antiretroviral combinations for the treatment of HIV infections (also known as highly active antiretroviral therapy or HAART).

To analyze the impact of HAART on patient survival, the investigators used a computer simulation model to examine national surveillance and efficacy data for newly diagnosed adult AIDS patients under care in the United States from 1989 to 2003. They divided those years into "eras" corresponding to specific advances in AIDS care, and then used the simulation model to determine per-person survival time for each era, compared to the absence of treatment.

The results: Per-person survival increased by three months in 1989-92 and then by two years in 1993-95; both eras were characterized by the introduction of certain measures to prevent opportunistic infections. But in the four HAART eras spanning 1996 to 2003, per-person survival increased by approximately eight, 11, 12, and 13 years. Over the past 10 years, the investigators concluded, widespread adoption of HAART regimens, in addition to prophylaxis, led to at least 3 million years of life saved in the United States. Moreover, since approximately 25 percent of those infected with HIV in the United States are estimated to be unaware of their infection and little more than half of those who are aware of it are actually in care, Dr. Walensky and coworkers calculated that "βοΏ½¦an additional 740,000 years of life might have been saved had all AIDS patients in the U.S. received appropriate treatment upon diagnosis."

In an accompanying editorial, Sten H. Vermund, MD, PhD, of Vanderbilt University observed that the benefits of HAART suggested by this study are greater than previously thought and may become still greater if certain barriers to care can be reduced or eliminated--such as the requirement for "extensive, expensive, time-consuming and intimidating" pre-test counseling for HIV infection. "If we address systematically the barriers to testing, care, and prevention," he concluded, "then future modelers will describe the next 15-year period as having saved hundreds of millions of life-years, not just in North America but around the globe."

Other authors of the study included A. David Paltiel, PhD, of Yale School of Medicine, Elena Losina, PhD, of Boston University School of Public Health, Lauren Mercincavage of Massachusetts General Hospital and Harvard Medical School, Bruce Schackman, PhD, of Weill Medical College of Cornell University, Paul Sax, MD, of Brigham and Women's Hospital and Harvard Medical School, and Milton Weinstein, PhD, of Harvard School of Public Health.

Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. Articles in JID include research results from microbiology, immunology, epidemiology, and related disciplines. JID is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Alexandria, Va., IDSA is a professional society representing about 8,000 physicians and scientists who specialize in infectious diseases. For more information, visit www.idsociety.org.


Story Source:

The above story is based on materials provided by Infectious Diseases Society of America. Note: Materials may be edited for content and length.


Cite This Page:

Infectious Diseases Society of America. "New Study Calculates Millions Of Years Saved In Lives Of AIDS Patients." ScienceDaily. ScienceDaily, 1 June 2006. <www.sciencedaily.com/releases/2006/06/060601175503.htm>.
Infectious Diseases Society of America. (2006, June 1). New Study Calculates Millions Of Years Saved In Lives Of AIDS Patients. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/06/060601175503.htm
Infectious Diseases Society of America. "New Study Calculates Millions Of Years Saved In Lives Of AIDS Patients." ScienceDaily. www.sciencedaily.com/releases/2006/06/060601175503.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins